Notably, the carbonylation of prolyl-4-hydroxylase beta (P4Hb) serves as an early target of autoimmunity and acts as a pathway that triggers an immune response involving insulin and/or proinsulin [37]. The gene discussed is INS; the disease is Autoimmunity.